Rabies immunoprohylaxis current recommendations;L'immuno-prophylaxie de la rage : Actualisation des recommandations

Presse Medicale

Volumn 25, Issue 22, 1996, Pages 1023-1027

  Strady, A ^a   Lang, J ^b   Rotivel, Y ^c   Jaussaud, R ^a   Fritzell, C ^c   Tsiang, H ^c  

^a SERVICE DE DERMATOLOGIE   (France)

^b Pasteur Mérieux ^*

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RABIES VACCINE;

GOOD CLINICAL PRACTICE; HUMAN; IMMUNOPROPHYLAXIS; RABIES; SHORT SURVEY; VACCINATION;

GUIDELINES; HUMANS; RABIES; RABIES VACCINES; RISK FACTORS; SEROLOGIC TESTS;

EID: 0029994464     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. WHO. Oral immunization of foxes in Europe in 1994. Weekly Epidemiol Record 1995 ; 70:89-91.
2. WHO. Two cases of imported rabies in France. Weekly Epidemiol Record 1992 ; 67:361-2.
3. Herzog M, Fritzell C, Lafage M, Montano Hirose JA, Scott-Algara D, Lafon M. T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin Exp Immunol 1991 ; 85:224-30.
4. Fedaku M, Shaddock JH, Sanderlin DW, Smith JS. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses. Vaccine 1988 ; 6:533-9.
5. Rollin P, Sureau P. La prophylaxie de la rage en France en 1991. Bull Epidemiol Heb 1992 ; 30:141-2.
6. WHO. Expert Committee on Rabies, 8th report, 1992. TRS 824, World Health Organization. Geneva.
7. Wilde H, Chomchey P, Prakongsri S, Punyaratabandhu P, Chutivongse S. Adverse effects of equine rabies immune globulin. Vaccine 1989 ; 7:10-11.
8. Wilde H, Choomkasien P, Hemachudha T, Supich C, Chutivongse S. Failure of rabies postexposure treatment in Thailand. Vaccine 1989 ; 7:49-52.
9. Fescharek R, Schwarz S, Quast U, Gandhi N, Karkhanis S. Postexposure rabies prophylaxis: when the guidelines are not respected. Vaccine 1991 ; 9:868-72.
10. WHO. WHO consultation on intradermal application of human rabies vaccines. Weekly Epidemiol Record 1995 ; 70:336-7.
11. Vodopija I, Sureau P, Smerdel S et al. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine 1988 ; 6:283-6.
12. Suntharasamai P, Chaiprasithikul P, Wasi C et al. A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis. Vaccine 1994 ; 12:508-12.
13. Strady A, Rouger C, Vernet V et al. Morsures d'animaux. Epidémiologie et risques infectieux. Presse Med 1988 ; 17:2229-33.
14. Anonyme. Liste des centres et des antennes de traitement antirabique. Bull Epidemiol Heb 1994 ; 40:134.
15. Bernard KB, Fishbein DB. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost. Vaccine 1991 ; 9:833-6.
16. Hatz CF, Bidaux JM, Eichenberger K, Mikulics U, Junghanss T. Circumstances and management of 72 animal bites among long-term residents in the tropics. Vaccine 1995 ; 13:811-15.
17. CDC. Rabies Prevention - United States, 1991. Recommendations of the Immunization Practices Committee (ACIP). MMWR 1991 ; 40:N°RR-3.
18. Rotivel Y, Fritzell C, Bourhy H, Tsiang H. Bilan de l'activité des centres antirabiques en 1992, 1993, 1994. Bull Epidemiol Heb 1996 ; 4:14-15.
19. Strady A, Lienard M, Ajjan N. Vaccination antirabique préventive en milieu professionnel exposé. Etude prospective et comparative d'immunogénicité sur 5 ans. Presse Med 1993 ; 22:572-5.
20. Phanuphak P, Khawplod P, Sriwanthana B, Phanpanich T, Wongurai S, Roumiantzeff M. Immunoenhancement with combined rabies and aluminium-adjuvanted tetanus vaccines. Vaccine 1989 ; 7:249-52.
21. Fritzell C, Rollin PE, Touir M, Sureau P, Teulieres L. Safety and immunogenicity of combined rabies and typhoid fever immunization. Vaccine 1992 ; 10:299-300.
22. Wilde H, Bhanghanada K. Chutiwongse S, Siakasem A. Boonchai W, Supich C. Is injection of contamined animal bite wounds with rabies immune globulin a safe practice? Trans R Soc Trop Med Hyg 1992 ; 86:86-8.
23. Wilde H, Khawplot P, Benjavongkulchai M, Sitprija V. Method of administration of rabies immune globulin. Vaccine 1994 ; 12:1150-1.
24. Sureau P, Rollin PE, Zeller H. Corrélations entre l'épreuve immurioenzymatique, la Séroneutralisation et la réduction de foyers fluorescents pour le titrage des anticorps rabiques. Comp Immunol Microbiol Infect 1982 ; 5:143-50.
25. Chutivongse S, Wilde H, Fishbein DB, Baer GM, Hemachudha T One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine. Vaccine 1991 ; 9:573-6.